https://doi.org/10.55788/42c9089e
Mr Federico Tancredi Magni (University Medical Center Groningen, the Netherlands) and colleagues analysed ablation strategies applied in patients with isolated pulmonary veins using data from all patients with repeat atrial fibrillation ablation recorded in the Netherlands Heart Registration [1]. Patients were included if they had atrial fibrillation with all pulmonary veins isolated during electrophysiologic mapping and were excluded if they had prior surgical ablation outside of the pulmonary veins or if re-ablation was due to atrial flutter or tachycardia. The analysis included a total of 274 patients.
The most common ablation strategy was posterior wall ablation (58.4%) followed by pulmonary vein antrum isolation (26.3%). A total of 12% of patients received no further ablation once durable pulmonary vein isolation was confirmed, while 41.2% of patients received an additional strategy, 32.1% of patients received 2 additional strategies, and 12.8% of patients had 3 additional strategies.
Over a follow-up of 2 years, 59.8% of patients had an atrial fibrillation recurrence and 12.7% of patients required re-ablation within the first year following their initial procedure. A multivariate adjusted analysis showed no association between the ablation strategy type and differences in atrial fibrillation occurrence. Furthermore, no statistically significant differences were seen in atrial fibrillation strategy, individual strategy as well as persistent atrial fibrillation; however, a higher risk of atrial fibrillation recurrence was seen in patients with a larger left atrium (HR 1.03; 95% CI 1.01–1.05).
In summary, in this cohort from the Netherlands Heart Registration, posterior wall ablation was the most commonly used ablation strategy. However, the atrial fibrillation recurrence rates were not associated with a particular ablation strategy or the number of strategies.
- Magni FT, et al. A multicenter evaluation of repeat ablation for atrial fibrillation in patients with isolated pulmonary veins: a Netherlands Heart Registration study. Atrial fibrillation: ablation 2,. EHRA Congress 2024, 7–9 April, Berlin, Germany.
Copyright ©2024 Medicom Medical Publishers
Posted on
Previous Article
« Factors associated with negative outcomes in post-operative atrial fibrillation Next Article
ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration »
« Factors associated with negative outcomes in post-operative atrial fibrillation Next Article
ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration »
Table of Contents: EHRA 2024
Featured articles
PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block
ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration
Personalising Ablation Techniques
Ablate-by-LAW: CT-determined left atrial wall thickness for ablation titration in atrial fibrillation
Personalised LAWT-guided ablation non-inferior to CLOSE protocol for paroxysmal atrial fibrillation
Style-AF: Improved outcomes with vascular closure versus figure-of-eight suture
Advantage of PREVENTIVE ablation plus implantable cardioverter-defibrillator in ischaemic cardiomyopathy
ASTRO AF: No benefit of staged left atrial appendage isolation cryoballoon ablation over radiofrequency ablation
Innovative Ablation Strategies
Pulsed-field ablation vs high-power short-duration radiofrequency in paroxysmal AF
CryoCure-VT: Endocardial ultra-low temperature cryoablation effective in sustained monomorphic ventricular tachycardia
PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block
MRI head-to-head comparison of lesion quality following various ablation techniques
“Single-shot” conformable catheter shows promising efficacy in paroxysmal atrial fibrillation
Post-Ablation Recurrence
AF burden versus classical AF classification in predicting arrhythmia recurrence
ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration
Ablation strategy and the number of repeat procedures not associated with atrial fibrillation recurrence
Factors associated with negative outcomes in post-operative atrial fibrillation
Arrhythmia Technologies
Smartphone rhythm monitoring optimises AF management following cardiac surgery
SMART-AV and SMART-CRT: Improved cardiac outcomes with algorithm-adapted atrioventricular delay
Premature battery depletion can affect a quarter of subcutaneous cardioverter defibrillators
New atrial fibrillation associated with a high risk of major cardiovascular outcomes
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com